相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
Sophie Testa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk
Alex C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
James D. Douketis et al.
JAMA INTERNAL MEDICINE (2019)
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
S. Testa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition)
Terese T. Horlocker et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2018)
Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial
James D. Douketis et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Population-based incidence rate of inpatient and outpatient surgical procedures in a high-income country
E. Omling et al.
BRITISH JOURNAL OF SURGERY (2018)
Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis
Joseph R. Shaw et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
Anne Godier et al.
EUROPEAN HEART JOURNAL (2017)
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
James D. Douketis et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study
Amy Y. X. Yu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures
A. Tripodi
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment
A. C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery
A. C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
Charles E. Frost et al.
CLINICAL PHARMACOKINETICS (2015)
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
James D. Douketis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations
Anne Godier et al.
THROMBOSIS RESEARCH (2015)
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
David Garcia et al.
BLOOD (2014)
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
Matthew W. Sherwood et al.
CIRCULATION (2014)
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013
Gilles Pernod et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2013)
Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
Vijay V. Upreti et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
How I treat anticoagulated patients undergoing an elective procedure or surgery
Alex C. Spyropoulos et al.
BLOOD (2012)
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates
Deborah Siegal et al.
CIRCULATION (2012)
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial
Jeff S. Healey et al.
CIRCULATION (2012)
Population pharmacokinetics and pharmacodynamics of rivaroxaban - An oral, direct factor Xa inhibitor in patients undergoing major orthopaedic surgery
Wolfgang Mueck et al.
CLINICAL PHARMACOKINETICS (2008)
Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects
Joachim Stangier et al.
CLINICAL PHARMACOKINETICS (2008)
Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects
Dagmar Kubitza et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The effect of extreme age, and gender, on the pharmacology and tolerability of rivaroxaban - An oral, direct factor Xa inhibitor.
Dagmar Kubitza et al.
BLOOD (2006)
Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
AS Go et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
